Lv1
40 积分 2024-08-24 加入
Emphysema Versus COPD in Patients Receiving Immune Checkpoint Inhibitors for NSCLC
1天前
已完结
Chronic obstructive pulmonary disease as a double-edged sword—reshaping NSCLC immunotherapy paradigms
1天前
求助中
Integrating magnetic field-initiated thermal-thermodynamic therapy and immune checkpoint blockade to boost antitumor immunotherapy
5天前
已关闭
Immune signatures predict development of autoimmune toxicity in patients with cancer treated with immune checkpoint inhibitors
15天前
已完结
Clinicopathological characteristics and therapeutic outcomes in patients with non-small cell lung cancer harboring SMARCA4 mutations
16天前
已完结
Old Molecules, New Hope: A Scoping Review and Bibliometric Analysis of Drug Repurposing for Lung Cancer
16天前
已完结
Intra-Tumoral Mucolytic Therapy for Unresectable Pseudomyxoma Peritonei: Results of a Single-Center Expanded Access Program
1个月前
已完结
Incidence and spectrum of immune-related adverse events in nasopharyngeal carcinoma patients treated with immune checkpoint inhibitors
1个月前
已完结
Incidence of Endocrine Dysfunction Following the Use of Different Immune Checkpoint Inhibitor Regimens
2个月前
已完结
Approach to the Patient With Immune Checkpoint Inhibitor-Associated Endocrine Dysfunction
2个月前
已完结
皖公网安备34019202002308
